Covidien’s Pipeline, NovoCure’s NovoTFF Set For FDA Panel Review
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Neurological Devices panel is set to review Covidien’s Pipeline embolization device and NovoCure’s NovoTFF-100A brain tumor treatment kit during a March 17-18 meeting.